Hutchison China MediTech Ltd ADR buy Bank of America Co.
Start price
22.07.25
/
50%
€14.60
Target price
22.07.26
€23.95
Performance (%)
-17.81%
Price
04.12.25
€11.90
Summary
This prediction is currently active. The prediction for Hutchison China MediTech Ltd ADR disappoints with a performance of -17.81%. This prediction currently runs until 22.07.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hutchison China MediTech Ltd ADR | -4.032% | -4.032% |
| iShares Core DAX® | 0.760% | -0.301% |
| iShares Nasdaq 100 | 0.732% | -1.001% |
| iShares Nikkei 225® | 1.025% | -3.621% |
| iShares S&P 500 | -0.036% | -0.194% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Hutchison China MediTech Ltd ADR diskutieren
HUTCHMED (China) Limited Sponsored ADR (NASDAQ: HCM) had its price target raised by analysts at Bank of America Corporation from $27.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for HCM provided by MarketBeat